BiotechTubeBiotechTube
Home/Investors/Medicxi

Medicxi

Biotech Investor · 4 portfolio companies

Portfolio
4
Combined Value
$8.5B
Focus Areas
11
Top Stage
Phase 2

Investment Focus

NeuroscienceSleep-Wake DisordersNeurodegenerative DisordersNeuropsychiatric DisordersOncologyCardiovascularMetabolic DiseasesDyslipidemiaSolid TumorsRespiratoryInfectious Disease

Portfolio Companies

CompanyValuation
Centessa Pharmaceuticals$4.0B
NewAmsterdam Pharma Company$3.3B
Bicara Therapeutics$1.2B
Altesa BioSciences—

Frequent Co-Investors

Forbion2 sharedAtlas Venture1 sharedFidelity1 sharedGeneral Atlantic1 sharedBVF Partners1 sharedRA Capital Management1 sharedFrazier Life Sciences1 sharedDeerfield Management1 shared